Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

New therapies in the management of rheumatoid arthritis.
Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice.
Phase II Study with Ocrelizumab Shows Significant Reduction in Disease Activity for Multiple Sclerosis Patients
Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
Efficacy and Safety of GTR in Comparison to Copaxone® (GATE)
A Study of Efficacy and Safety of Ocrelizumab in Patients with Relapse-Remitting Multiple Sclerosis
CellCept (Product Insert)
The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement.
Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis.
A network meta-analysis of randomized controlled trials for comparing the effectiveness and safety profile of treatments with marketing authorization for relapsing multiple sclerosis.
Ocrelizumab Bests Interferon in Relapsing-Remitting MS
Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison.
LINGO-1 negatively regulates myelination by oligodendrocytes.
U.S. FDA grants Breakthrough Therapy Designation for Roche’s investigational medicine ocrelizumab in primary progressive multiple sclerosis
Autoimmunity's next top models.
Protective effect of breastfeeding in postpartum relapse rate of mothers with multiple sclerosis.
Roche’s ocrelizumab first investigational medicine to show efficacy in people with primary progressive multiple sclerosis in large Phase III study
CXCL12-induced monocyte-endothelial interactions promote lymphocyte transmigration across an in vitro blood-brain barrier.
Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis.
Multiple sclerosis and pregnancy: experience from a nationwide database in Germany.
Histologie de la sclerose en plaques
The origin and application of experimental autoimmune encephalomyelitis.
Genentech’s ocrelizumab Significantly Reduced Both Relapses and Disability Progression versus interferon beta-1a (Rebif®) in Two Phase III Studies in Multiple Sclerosis
Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity.
Comparison of Relapse and Treatment Failure Rates Among Patients With Neuromyelitis Optica: Multicenter Study of Treatment Efficacy.

Pages